M Mahmun Hossain

Chemistry & Biochemistry
 Chemistry 745

Dr. Hossain’s group is interested to develop novel organic reactions that will simplify the synthesis of existing biologically active compounds and also enable the generation of a new class of therapeutics for human diseases. Currently, his group is focused on developing a new and concise synthetic procedure for tryptophan-based anti-cancer microtubule inhibitors tryprostatin A and B and their analogs. In addition, his group is involved in developing new oxindole and benzofuran-based analgesic drugs.

M. Mahmun Hossain’s website